Navigation Links
Scientists uncover secrets of potential bioterror virus
Date:2/17/2009

GALVESTON, Texas Researchers at the University of Texas Medical Branch at Galveston have discovered a key tactic that the Rift Valley fever virus uses to disarm the defenses of infected cells.

The mosquito-borne African virus causes fever in humans, inflicting liver damage, blindness and even death on a small percentage of the people it infects. Rift Valley fever also afflicts cattle, goats and sheep, resulting in a nearly 100 percent abortion rate in these animals. Its outbreaks periodically cause economic devastation in parts of Kenya, Somalia, Sudan and Zimbabwe, and bioterrorism experts warn that its introduction to the United States would cripple the North American beef industry.

"It's really important to know how this virus causes disease, and that's what we're doing here, working to understand its pathogenicity at the molecular level," said assistant professor Tetsuro Ikegami, lead author of a paper on the discovery now appearing in PLoS Pathogens.

Ikegami and his collaborators focused on a viral protein called NSs. The protein was already known to be a major factor in making Rift Valley fever more virulent; earlier research had shown that it penetrated cell nuclei and disrupted the coding of RNA messages, including those ordering the production of the antiviral protein interferon beta.

"We didn't know what the mechanism was, but we suspected NSs had some additional function that would promote viral replication," Ikegami said. So starting with an already weakened strain of Rift Valley fever virus produced as part of a vaccine development project he created a genetically engineered form of the virus that lacked the genes for NSs.

Safety precautions make working with natural, "wild-type" Rift Valley fever virus difficult; at UTMB, investigations are restricted to a tightly secured biosafety level 4 lab, where researchers work in protective, full-body "spacesuits." By contrast, the vaccine strain of the virus that Ikegami modified, known as MP-12, can safely be handled inside a standard biosafety cabinet.

Using the NSs-free mutant virus to perform a series of cell-culture experiments, the researchers found that NSs does in fact have a second function. It attacks a protein called PKR, the beginning of a chain of biochemical reactions leading to the accumulation of a molecular complex known as phosphorylated eIF2-alpha. Phosphorylated eIF2-alpha suppresses overall protein production. Unblocked, it would prevent Rift Valley fever virus from using cellular protein synthesis machinery to make the proteins it needs to replicate itself. But since NSs prevents the phosphorylation of eIF2-alpha by taking out PKR, the virus is free to copy itself within host cells without interference.

"It's amazing that the virus evolved to use one protein to do two jobs, to use its very limited genetic information to perform these very different functions," said microbiology and immunology professor Shinji Makino, senior author of the paper. "It's really interesting, and it's also important, because these types of experiments are critical to learning how to control this virus."


'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... feature 150+ Hospital and Health System Executive Speakers including: , , ... of the United States of America: George W. Bush , Boxing Legend, Successful ... Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber McGraw Walsh , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... help improve all aspects of people’s health and nutrition, announced its product Leyzene ... , Natural Subsistence develops nutritional supplements that help people improve all aspects ...
(Date:3/23/2017)... ... 2017 , ... The American Board of Quality Assurance and Utilization Review Physicians ... to Health Care Quality and Management and Patient Safety. , It is with appreciation ... but also to the Health Care Quality and Patient Safety movements. Diplomates and Members ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, ... How will the new EU MDR language change the way manufacturers approach ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Beyond and ... “Beyond and Back” is the creation of published author Bonetta Rose, a wife, mother ... our lives. , Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017  The goal of the ... identify and track prescription drugs as they are distributed ... response to requirements from US FDA to better protect ... dangerous medicines. Blockchain startup Chronicled, which ... chips and blockchain technology and recently raised $6.25M, and ...
(Date:3/23/2017)... Prima BioMed has presented encouraging ... IMP321 in combination with Keytruda, with one of the ... a complete response. Recruitment in the second cohort is ... fully recruited by Q317. Preliminary efficacy data from the ... are expected mid-year (recruitment in the 226-patient Phase IIb ...
(Date:3/23/2017)... , March 23, 2017 ... ended the trading session at 5,821.64, up 0.48%; ... to finish at 20,661.30; and the S&P 500 ... broad based as six out of nine sectors ... has initiated reports coverage on the following Medical ...
Breaking Medicine Technology: